B-cell compartment as the selective target for the treatment of immune thrombocytopenias.
about
Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature.Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases.B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis.
P2860
B-cell compartment as the selective target for the treatment of immune thrombocytopenias.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
B-cell compartment as the selective target for the treatment of immune thrombocytopenias.
@ast
B-cell compartment as the selective target for the treatment of immune thrombocytopenias.
@en
type
label
B-cell compartment as the selective target for the treatment of immune thrombocytopenias.
@ast
B-cell compartment as the selective target for the treatment of immune thrombocytopenias.
@en
prefLabel
B-cell compartment as the selective target for the treatment of immune thrombocytopenias.
@ast
B-cell compartment as the selective target for the treatment of immune thrombocytopenias.
@en
P2093
P1433
P1476
B-cell compartment as the selective target for the treatment of immune thrombocytopenias.
@en
P2093
Alessandra Sperotto
Alfonso Zaccaria
Anna Lia Molinari
Francesco Zaja
Isabella Iacona
Monica Tani
Nicola Vianelli
Paola Masolini
Renato Fanin
Salvatore De Vita
P304
P577
2003-05-01T00:00:00Z